<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="ja">
	<id>https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=16%CE%B1-Hydroxyestrone</id>
	<title>16α-Hydroxyestrone - 版の履歴</title>
	<link rel="self" type="application/atom+xml" href="https://bsd.neuroinf.jp/w/index.php?action=history&amp;feed=atom&amp;title=16%CE%B1-Hydroxyestrone"/>
	<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=16%CE%B1-Hydroxyestrone&amp;action=history"/>
	<updated>2026-04-15T07:30:55Z</updated>
	<subtitle>このウィキのこのページに関する変更履歴</subtitle>
	<generator>MediaWiki 1.43.8</generator>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=16%CE%B1-Hydroxyestrone&amp;diff=49686&amp;oldid=prev</id>
		<title>WikiSysop: 1版 をインポートしました</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=16%CE%B1-Hydroxyestrone&amp;diff=49686&amp;oldid=prev"/>
		<updated>2025-03-18T10:26:42Z</updated>

		<summary type="html">&lt;p&gt;1版 をインポートしました&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;ja&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← 古い版&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;2025年3月18日 (火) 19:26時点における版&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;4&quot; class=&quot;diff-notice&quot; lang=&quot;ja&quot;&gt;&lt;div class=&quot;mw-diff-empty&quot;&gt;(相違点なし)&lt;/div&gt;
&lt;/td&gt;&lt;/tr&gt;
&lt;!-- diff cache key wiki-mw_:diff:1.41:old-49685:rev-49686 --&gt;
&lt;/table&gt;</summary>
		<author><name>WikiSysop</name></author>
	</entry>
	<entry>
		<id>https://bsd.neuroinf.jp/w/index.php?title=16%CE%B1-Hydroxyestrone&amp;diff=49685&amp;oldid=prev</id>
		<title>bsd&gt;JWBE: removed Category:Phenols; added Category:Hydroxyarenes using HotCat</title>
		<link rel="alternate" type="text/html" href="https://bsd.neuroinf.jp/w/index.php?title=16%CE%B1-Hydroxyestrone&amp;diff=49685&amp;oldid=prev"/>
		<updated>2024-10-21T16:12:02Z</updated>

		<summary type="html">&lt;p&gt;removed &lt;a href=&quot;/w/index.php?title=%E3%82%AB%E3%83%86%E3%82%B4%E3%83%AA:Phenols&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;カテゴリ:Phenols (存在しないページ)&quot;&gt;Category:Phenols&lt;/a&gt;; added &lt;a href=&quot;/w/index.php?title=%E3%82%AB%E3%83%86%E3%82%B4%E3%83%AA:Hydroxyarenes&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;カテゴリ:Hydroxyarenes (存在しないページ)&quot;&gt;Category:Hydroxyarenes&lt;/a&gt; using &lt;a href=&quot;/w/index.php?title=WP:HC&amp;amp;action=edit&amp;amp;redlink=1&quot; class=&quot;new&quot; title=&quot;WP:HC (存在しないページ)&quot;&gt;HotCat&lt;/a&gt;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;新規ページ&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Chembox&lt;br /&gt;
&amp;lt;!-- Images --&amp;gt;&lt;br /&gt;
| ImageFile = 16α-Hydroxyestrone.svg&lt;br /&gt;
| ImageSize = 250&lt;br /&gt;
| ImageAlt =&lt;br /&gt;
&amp;lt;!-- Names --&amp;gt;&lt;br /&gt;
| IUPACName = 3,16α-Dihydroxyestra-1,3,5(10)-trien-17-one&lt;br /&gt;
| SystematicName = (2&amp;#039;&amp;#039;R&amp;#039;&amp;#039;,3a&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,3b&amp;#039;&amp;#039;R&amp;#039;&amp;#039;,9b&amp;#039;&amp;#039;S&amp;#039;&amp;#039;,11a&amp;#039;&amp;#039;S&amp;#039;&amp;#039;)-2,7-Dihydroxy-11a-methyl-2,3,3a,3b,4,5,9b,10,11,11a-decahydro-1&amp;#039;&amp;#039;H&amp;#039;&amp;#039;-cyclopenta[&amp;#039;&amp;#039;a&amp;#039;&amp;#039;]phenanthren-1-one&lt;br /&gt;
| OtherNames = Hydroxyestrone; 16-Hydroxyestrone&lt;br /&gt;
&amp;lt;!-- Sections --&amp;gt;&lt;br /&gt;
| Section1 = {{Chembox Identifiers&lt;br /&gt;
| CASNo = 566-76-7&lt;br /&gt;
| CASNo_Ref = {{cascite|correct|CAS}}&lt;br /&gt;
| UNII_Ref = {{fdacite|correct|FDA}}&lt;br /&gt;
| UNII = JY611949JU&lt;br /&gt;
| ChemSpiderID = 103012&lt;br /&gt;
| ChEBI = 776&lt;br /&gt;
| InChI = 1S/C18H22O3/c1-18-7-6-13-12-5-3-11(19)8-10(12)2-4-14(13)15(18)9-16(20)17(18)21/h3,5,8,13-16,19-20H,2,4,6-7,9H2,1H3/t13-,14-,15+,16-,18+/m1/s1&lt;br /&gt;
| PubChem = 115116&lt;br /&gt;
| SMILES = C[C@]12CC[C@H]3[C@H]([C@@H]1C[C@H](C2=O)O)CCC4=C3C=CC(=C4)O&lt;br /&gt;
  }}&lt;br /&gt;
| Section2 = {{Chembox Properties&lt;br /&gt;
| C=18 | H=22 | O=3&lt;br /&gt;
| Appearance = &lt;br /&gt;
| Density = &lt;br /&gt;
| MeltingPt = &lt;br /&gt;
| BoilingPt = &lt;br /&gt;
| Solubility = &lt;br /&gt;
  }}&lt;br /&gt;
| Section3 = {{Chembox Hazards&lt;br /&gt;
| MainHazards =&lt;br /&gt;
| FlashPt =&lt;br /&gt;
| AutoignitionPt =&lt;br /&gt;
  }}&lt;br /&gt;
}}&lt;br /&gt;
&lt;br /&gt;
&amp;#039;&amp;#039;&amp;#039;16α-Hydroxyestrone&amp;#039;&amp;#039;&amp;#039; (&amp;#039;&amp;#039;&amp;#039;16α-OH-E1&amp;#039;&amp;#039;&amp;#039;), or &amp;#039;&amp;#039;&amp;#039;hydroxyestrone&amp;#039;&amp;#039;&amp;#039;, also known as &amp;#039;&amp;#039;&amp;#039;estra-1,3,5(10)-triene-3,16α-diol-17-one&amp;#039;&amp;#039;&amp;#039;, is an [[endogenous]] [[steroid]]al [[estrogen]] and a major [[metabolite]] of [[estrone]], as well as an [[metabolic intermediate|intermediate]] in the [[biosynthesis]] of [[estriol]].&amp;lt;ref name=&amp;quot;Rakel2012&amp;quot;&amp;gt;{{cite book|first = David | last = Rakel | name-list-style = vanc |title=Integrative Medicine|url=https://books.google.com/books?id=jlVtJzBwAcEC&amp;amp;pg=PA338|year=2012|publisher=Elsevier Health Sciences|isbn=978-1-4377-1793-8|pages=338–339}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;AcademicPress2005&amp;quot;&amp;gt;{{cite book|title=Vitamins and Hormones|url=https://books.google.com/books?id=DUst5mwBfN0C&amp;amp;pg=PA282|date=7 September 2005|publisher=Academic Press|isbn=978-0-08-045978-3|pages=282–}}&amp;lt;/ref&amp;gt; It is a potent estrogen similarly to estrone, and it has been suggested that the ratio of 16α-hydroxyestrone to [[2-hydroxyestrone]], the latter being much less estrogenic in comparison and even [[antiestrogen]]ic in the presence of more potent estrogens like [[estradiol]], may be involved in the [[pathophysiology]] of [[breast cancer]].&amp;lt;ref name=&amp;quot;Rakel2012&amp;quot; /&amp;gt; Conversely, 16α-hydroxyestrone may help to protect against [[osteoporosis]].&amp;lt;ref name=&amp;quot;Rakel2012&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
In terms of [[relative binding affinity]] (RBA) for the rat [[uterus|uterine]] [[estrogen receptor]], 16α-hydroxyestrone showed 2.8% of the [[affinity (pharmacology)|affinity]] of [[estradiol (medication)|estradiol]].&amp;lt;ref name=&amp;quot;pmid7190977&amp;quot;&amp;gt;{{cite journal | vauthors = Fishman J, Martucci C | title = Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology | journal = J. Clin. Endocrinol. Metab. | volume = 51 | issue = 3 | pages = 611–5 | date = September 1980 | pmid = 7190977 | doi = 10.1210/jcem-51-3-611 }}&amp;lt;/ref&amp;gt; For comparison, [[estrone (medication)|estrone]] had 11% of the affinity and [[estriol (medication)|estriol]] had 10% of the affinity of estradiol.&amp;lt;ref name=&amp;quot;pmid7190977&amp;quot; /&amp;gt; In contrast to other estrogens, the binding  of 16α-hydroxyestrone to the estrogen receptor is reported to be [[covalent bond|covalent]] and [[irreversible agonist|irreversible]].&amp;lt;ref name=&amp;quot;OettelSchillinger2012&amp;quot;&amp;gt;{{cite book | first1 = Michael | last1 = Oettel | first2 = Ekkehard | last2 = Schillinger | name-list-style = vanc |title=Estrogens and Antiestrogens I: Physiology and Mechanisms of Action of Estrogens and Antiestrogens|url=https://books.google.com/books?id=0BfrCAAAQBAJ&amp;amp;pg=PA252|date=6 December 2012|publisher=Springer Science &amp;amp; Business Media|isbn=978-3-642-58616-3|pages=252–}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid3186693&amp;quot;&amp;gt;{{cite journal | vauthors = Swaneck GE, Fishman J | title = Covalent binding of the endogenous estrogen 16 alpha-hydroxyestrone to estradiol receptor in human breast cancer cells: characterization and intranuclear localization | journal = Proc. Natl. Acad. Sci. U.S.A. | volume = 85 | issue = 21 | pages = 7831–5 | date = November 1988 | pmid = 3186693 | pmc = 282290 | doi = 10.1073/pnas.85.21.7831 | bibcode = 1988PNAS...85.7831S | doi-access = free }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid9472688&amp;quot;&amp;gt;{{cite journal | vauthors = Zhu BT, Conney AH | title = Functional role of estrogen metabolism in target cells: review and perspectives | journal = Carcinogenesis | volume = 19 | issue = 1 | pages = 1–27 | date = January 1998 | pmid = 9472688 | doi = 10.1093/carcin/19.1.1 | doi-access = free }}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;pmid16112947&amp;quot;&amp;gt;{{cite journal | vauthors = Kuhl H | title = Pharmacology of estrogens and progestogens: influence of different routes of administration | journal = Climacteric | volume = 8 | pages = 3–63 | year = 2005 | issue = Suppl 1 | pmid = 16112947 | doi = 10.1080/13697130500148875 | s2cid = 24616324 | url = http://hormonebalance.org/images/documents/Kuhl%2005%20%20Pharm%20Estro%20Progest%20Climacteric_1313155660.pdf}}&amp;lt;/ref&amp;gt; 16α-Hydroxyestrone has been reported to have 25% of the [[vagina]]l [[estrogen (medication)|estrogen]]ic [[potency (pharmacology)|potency]] of estradiol.&amp;lt;ref name=&amp;quot;pmid7190977&amp;quot;&amp;gt;{{cite journal | vauthors = Fishman J, Martucci C | title = Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology | journal = J. Clin. Endocrinol. Metab. | volume = 51 | issue = 3 | pages = 611–5 | date = September 1980 | pmid = 7190977 | doi = 10.1210/jcem-51-3-611 }}&amp;lt;/ref&amp;gt; The maximal [[uterotrophic]] and [[antigonadotropic]] effect of 16α-hydroxyestrone was equivalent to those of estradiol and estriol, indicating that 16α-hydroxyestrone is a fully effective estrogen.&amp;lt;ref name=&amp;quot;pmid7190977&amp;quot; /&amp;gt;&amp;lt;ref name=&amp;quot;Velardo1964&amp;quot;&amp;gt;{{cite book|last1=Velardo|first1=Joseph Thomas|title=Hormonal Steroids Biochemistry, Pharmacology, and Therapeutics|chapter=The Actions of Steroid Hormones on Estradiol-17β in Uterine Growth and Enzymorphology|year=1964|pages=463–490|doi=10.1016/B978-0-12-395506-7.50065-0|isbn=9780123955067}}&amp;lt;/ref&amp;gt; However, 16α-hydroxyestrone was much less potent than estradiol or estrone.&amp;lt;ref name=&amp;quot;Velardo1964&amp;quot; /&amp;gt;&lt;br /&gt;
&lt;br /&gt;
The C3 and C16α [[acetate|diacetate]] [[ester]] of 16α-hydroxyestrone, [[hydroxyestrone diacetate]] (brand names Colpoginon, Colpormon, Hormobion, and Hormocervix), has been marketed and used medically as an estrogen in [[Europe]].&amp;lt;ref name=&amp;quot;IndexNominum2000&amp;quot;&amp;gt;{{cite book|title=Index Nominum 2000: International Drug Directory|url=https://books.google.com/books?id=5GpcTQD_L2oC&amp;amp;pg=PA1250|date=January 2000|publisher=Taylor &amp;amp; Francis|isbn=978-3-88763-075-1|pages=1250–}}&amp;lt;/ref&amp;gt;&amp;lt;ref name=&amp;quot;Muller1998&amp;quot;&amp;gt;{{cite book| first1 = Niels F | last1 = Muller | first2 = Rudolf P | last2 = Dessing | author3 = European Society of Clinical Pharmacy | name-list-style = vanc |title=European Drug Index: European Drug Registrations | edition = Fourth|url=https://books.google.com/books?id=2HBPHmclMWIC&amp;amp;pg=PA289|date=19 June 1998|publisher=CRC Press|isbn=978-3-7692-2114-5|pages=289–}}&amp;lt;/ref&amp;gt;&lt;br /&gt;
&lt;br /&gt;
{{Selected biological properties of endogenous estrogens in rats}}&lt;br /&gt;
&lt;br /&gt;
==See also==&lt;br /&gt;
* [[2-Hydroxyestrone]]&lt;br /&gt;
* [[2-Hydroxyestradiol]]&lt;br /&gt;
* [[16β-Hydroxyestrone]]&lt;br /&gt;
* [[16-Ketoestrone]]&lt;br /&gt;
* [[16α-Hydroxydehydroepiandrosterone]]&lt;br /&gt;
* [[16α-Hydroxyandrostenedione]]&lt;br /&gt;
* [[15α-Hydroxydehydroepiandrosterone]]&lt;br /&gt;
&lt;br /&gt;
==References==&lt;br /&gt;
{{Reflist}}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
{{Endogenous steroids}}&lt;br /&gt;
{{Estrogen receptor modulators}}&lt;br /&gt;
&lt;br /&gt;
{{DEFAULTSORT:Hydroxyestrone, 16α-}}&lt;br /&gt;
&lt;br /&gt;
[[Category:Acyloins]]&lt;br /&gt;
[[Category:Estranes]]&lt;br /&gt;
[[Category:Estrogens]]&lt;br /&gt;
[[Category:Human metabolites]]&lt;br /&gt;
[[Category:Hydroxyarenes]]&lt;/div&gt;</summary>
		<author><name>bsd&gt;JWBE</name></author>
	</entry>
</feed>